SEC 13F Intelligence

Orbimed Advisors LLC / GPCR

Orbimed Advisors LLC’s Structure Therapeutics Inc Position

Does Orbimed Advisors LLC own Structure Therapeutics Inc (GPCR)? Yes — 1.48M shares worth $71M (+1.41% of its 13F portfolio) as of Q1 2026, up from 1.16M shares the prior filed quarter.

Position Value
$71M
Q1 2026
Shares
1.48M
% of Portfolio
+1.41%
Quarters Held
8
currently held

Position History GPCR

Reported value by quarter
Q2 ’24: $5MQ2 ’24Q3 ’24: $17MQ3 ’24Q4 ’24: $18MQ4 ’24Q1 ’25: $11MQ1 ’25Q2 ’25: $25MQ2 ’25Q3 ’25: $32MQ3 ’25Q4 ’25: $81MQ4 ’25Q1 ’26: $71MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.48M$71M+1.41%
Q4 20251.16M$81M+1.65%
Q3 20251.14M$32M+0.75%
Q2 20251.20M$25M+0.62%
Q1 2025652.0K$11M+0.27%
Q4 2024652.0K$18M+0.36%
Q3 2024383.7K$17M+0.31%
Q2 2024125.0K$5M+0.10%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of GPCR.